Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Fuji
US Army
Colorcon
Accenture
Cipla
Cantor Fitzgerald
Citi
AstraZeneca
Healthtrust
Medtronic

Generated: August 20, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 017875

« Back to Dashboard
NDA 017875 describes LOESTRIN 21 1.5/30, which is a drug marketed by Apil and is included in one NDA. It is available from two suppliers. Additional details are available on the LOESTRIN 21 1.5/30 profile page.

The generic ingredient in LOESTRIN 21 1.5/30 is ethinyl estradiol; norethindrone acetate. There are twenty-six drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; norethindrone acetate profile page.

Summary for NDA: 017875

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Formulation / Manufacturing:see details

Suppliers and Packaging for NDA: 017875

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
LOESTRIN 21 1.5/30
ethinyl estradiol; norethindrone acetate
TABLET;ORAL-21 017875 NDA AUTHORIZED GENERIC Mayne Pharma Inc. 51862-279 51862-279-06 6 BLISTER PACK in 1 CARTON (51862-279-06) > 21 TABLET in 1 BLISTER PACK
LOESTRIN 21 1.5/30
ethinyl estradiol; norethindrone acetate
TABLET;ORAL-21 017875 NDA AUTHORIZED GENERIC Actavis Pharma, Inc. 52544-290 52544-290-21 6 BLISTER PACK in 1 CARTON (52544-290-21) > 21 TABLET in 1 BLISTER PACK

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORAL-21Strength0.03MG;1.5MG
Approval Date:Approved Prior to Jan 1, 1982TE:ABRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

McKinsey
Chubb
Teva
Healthtrust
Baxter
Chinese Patent Office
Covington
Medtronic
Fish and Richardson
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot